Sam Brusco, Associate Editor04.14.21
BioSig Technologies Inc. released Software Version 4 for the PURE EP System. This release builds on PURE EP’s main system capabilities while improving user experience, and the upgrade will be rolled out to all new and existing customers.
The update adds tools to shorten system set up time and bring features for faster real-time signal analysis, potentially improving EP procedures’ efficiency and accuracy.
Software Version 4 updates include user interface enhancements for a more compelling arrhythmia morphology assessment, clinical template management, and functionalities for real-time signal visualization—such as “Differential Analysis” allowing simultaneous display of a channel using various filter settings to assess specific signal characteristics or the enhanced “Digital Zoom” to instantly focus on crucial physiologic details while maintaining a high signal-to-noise ratio.
“The launch of the PURE EP Software Version 4 is the result of a collaborative effort between our engineering team and our physician customers to identify the most critical needs and translate those into innovative advancements. Our comprehensive product portfolio consists of a series of commercial software upgrades and novel software modules, and we are dedicated to driving the innovation as we accelerate commercial sales this year,” Olivier Chaudoir, sr. director of marketing at BioSig Technologies, told the press.
Over 660 patient cases have been conducted using the PURE EP System to date.
The update adds tools to shorten system set up time and bring features for faster real-time signal analysis, potentially improving EP procedures’ efficiency and accuracy.
Software Version 4 updates include user interface enhancements for a more compelling arrhythmia morphology assessment, clinical template management, and functionalities for real-time signal visualization—such as “Differential Analysis” allowing simultaneous display of a channel using various filter settings to assess specific signal characteristics or the enhanced “Digital Zoom” to instantly focus on crucial physiologic details while maintaining a high signal-to-noise ratio.
“The launch of the PURE EP Software Version 4 is the result of a collaborative effort between our engineering team and our physician customers to identify the most critical needs and translate those into innovative advancements. Our comprehensive product portfolio consists of a series of commercial software upgrades and novel software modules, and we are dedicated to driving the innovation as we accelerate commercial sales this year,” Olivier Chaudoir, sr. director of marketing at BioSig Technologies, told the press.
Over 660 patient cases have been conducted using the PURE EP System to date.